CANCER BUZZ

After 6 years of bringing listeners key insights into the most pressing topics in oncology, ACCC's podcast, CANCER BUZZ, has gotten a facelift! In this episode, CANCER BUZZ brings back our first podcast guest, Tina Curtis, DNP, MBA, RN, NEA-BC, executive director of cancer services at Froedtert Hospital. In the June 26, 2019, inaugural CANCER BUZZ episode, Dr. Curtis spoke about her institution's...

US Veterans are at a heightened risk for lung cancer due to service-related exposures. Integrating clinical research into routine oncology care at the US Department of Veterans Affairs (VA) can help bring clinical trials closer to where Veterans live and improve access to cutting edge therapies. In this episode, CANCER BUZZ speaks with Millie Das, MD, chief of oncology at the VA Palo Alto Health C...

Fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) is an emerging biomarker present in about 38% of patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma. In this episode, CANCER BUZZ speaks with Nataliya Uboha, MD, PhD, a medical oncologist at University of Wisconsin Health, about current recommendations for biomarker testing in this population, emerging biomarke...

In metastatic breast cancer, resistance to therapy remains one of the most challenging aspects to care. A key driver of resistance in hormone receptor-positive, HER2-negative disease is the ESR1 mutation, a genetic change that alters the estrogen receptor and limits the effectiveness of certain standard therapies. In this episode, CANCER BUZZ speaks with Eleonara Teplinsky, MD, FASCO, head of brea...

Una Hopkins, DNP, MSN, FNP-BC, NE-BC, RN, FACCC, president of the Association of Cancer Care Centers (ACCC) designated her theme for the 2025-2026 year as Designing Oncology Care to Meet the Needs of a Growing Patient Population in response to forecasts predicting both patient and survivor populations will grow in coming years. In this episode, CANCER BUZZ speaks with Dr. Hopkins about the importa...

Synopsis: Live this week from the ACCC 42nd National Oncology Conference (NOC), CANCER BUZZ speaks with Dr. Deirdre Saulet, who discusses highlights from Friday morning's panel session: Women Leaders in Oncology: Exploring Successful Dyad Models.  Guest:  Deirdre Saulet, PhD Chief Strategy Officer Jasper Health   Resources:  ACCC 42nd National Oncology Conference Agenda  

Live this week from the ACCC 42nd National Oncology Conference (NOC), CANCER BUZZ catches up with attendees who highlight takeaways from this year's hot topic sessions. Guests:  Laura Kuzma  Administrative Director FirstHealth of the Carolinas   Brittany McArn, OPN-CG, CPPN Financial Navigation Manager Outpatient Oncology Services FirstHealth of the Carolinas     Resources:  ACCC 42nd National Onc...

Live this week from the ACCC 42nd National Oncology Conference (NOC), CANCER BUZZ shares highlights from the President's Fireside Chat, where Una Hopkins leads a dynamic conversation with oncology providers from 3 cancer programs that are designing innovative care models to meet the needs of a growing patient population. Speakers:  Dr. Una Hopkins President, ACCC Director, Nursing Research Montefi...

Live this week from the ACCC's 42nd National Oncology Conference (NOC), CANCER BUZZ speaks with ACCC Board of Trustees member Jennifer Bires, who details the highlights from the Wednesday panel discussion she led, "POPS: Navigating Quality Integrative Cancer Support Resources." Guest:  Jennifer Bires , MSW, LCSW, OSW-C, FACCC Executive Director, Life with Cancer and Patient Experience Inova Health...

Live this week from the ACCC's 42nd National Oncology Conference (NOC), CANCER BUZZ speaks with ACCC Executive Director Meagan O'Neill, MS, who previews the week.  Guest:  Meagan O'Neill, MS Executive Director, Association of Cancer Care Centers   Resources:  ACCC 42nd National Oncology Conference Agenda  

Since 2010, the Association of Cancer Care Centers (ACCC) has produced an annual Trending Now in Cancer Care report, highlighting the biggest challenges, solutions, and opportunities in oncology. In this episode, CANCER BUZZ speaks with Lindsey Causey, DNP, APRN, ANP-BC, AOCNP, nurse practitioner at Cone Health Cancer Center, about part 2 of the 2025 trend report. She shares takeaways from the in-...

Since 2010, the Association of Cancer Care Centers (ACCC) has produced an annual Trending Now in Cancer Care report, highlighting the biggest challenges, solutions, and opportunities in oncology. In this episode, CANCER BUZZ speaks with Calliope Bodenhorn Payne, MHA, virtual care coordinator at Texas Oncology, about part 1 of the 2025 trend report. She shares takeaways from the in-person discussio...

The George Washington Cancer Center serves a racially, ethnically, and socioeconomically diverse population across Washington, D.C., northern Virginia, and southern Maryland. Their Breast Cancer Program has found that a community-informed model is most successful for managing care and adverse events related to CDK4/6 inhibitors. In this episode, CANCER BUZZ speaks with Pavani Chalasani, MD, MPH, d...

It is essential for adolescents and young adults (AYAs) to have a foundation of care prior to discharge after their cancer treatment , and the multidisciplinary care team, including primary care providers (PCPs), must be equipped to support these patients. In this episode, CANCER BUZZ speaks with Scott J. Capozza, PT, MSPT, on his journey navigating care after cancer treatment as a young adult and...

Advanced practice providers (APPs) play an increasingly vital role in delivering high-quality, team-based care. APPs need the right support and structure when stepping into the complex world of oncology, through thoughtful onboarding programs. It is essential to spotlight effective APP onboarding models across various practice settings, including academic, comprehensive, and community settings. Mu...

According to Blood Cancer United (formerly the Leukemia & Lymphoma Society), approximately every 3 minutes, 1 person in the United States is diagnosed with leukemia, lymphoma, or myeloma. AML is a heterogeneous hematologic malignancy; despite advances in treatment, AML remains challenging to cure. Integrating new treatment options for patients with refractory acute myeloid leukemia (AML), includin...

In this episode, CANCER BUZZ speaks with Susan Salgado, PhD, keynote speaker at the upcoming 42nd National Oncology Conference, about her approach to organizational culture and leadership. With over 2 decades of experience in consulting spanning more than 20 industries, Dr. Salgado is adept at transferring hospitality skills to the field of health care. She discusses the importance of zeroing in o...

Clinical research is critical to the development of life saving treatments. And ACCC has long supported equitable access to clinical trials, including efforts to ensure that these trials reflect the diversity of the populations they serve. ACCC has made the  Just ASK ™ Training Program and Site Self-Assessment available free-of-charge to help research sites address barriers to participation in can...

The high cost associated with cancer diagnosis, treatment, and survivorship makes the burden of financial toxicity an unavoidable reality for many patients—and makes financial navigators central to the delivery of high-quality cancer care. In this vodcast episode, CANCER BUZZ speaks with Heather Simpson, BCPA, patient financial navigator lead, who shares her experience using the ACCC Financial Adv...

Effective management of adverse events and addressing barriers to care are critical to optimizing outcomes and maintaining quality of life for patients receiving CDK4/6 inhibitors. In this episode, CANCER BUZZ speaks with Julia Lea Ziegengeist, PharmD, BCOP, clinical pharmacist coordinator in solid tumor oncology at Atrium Health Levine Cancer Institute about proactive, team-based strategies to id...

Clinical trials are vital to offering and developing the most effective treatment options. However, there are large disparities in enrollment across race, ethnicity, geography, and type of cancer care center. Mary Bird Perkins Cancer Center in Baton Rouge, LA uses local partnerships, culturally tailored outreach, and workforce innovation to drive sustainable and equitable participation in clinical...

Anticipating and managing CDK4/6 inhibitor toxicities in HR+ HER2- breast cancer is essential to improving patient quality of life and optimizing clinical outcomes. In this episode, CANCER BUZZ speaks with Diana Van Ostran, PharmD, BCOP, clinical pharmacy specialist – breast clinic at Miami Cancer Institute, Baptist Health South Florida, about strategies to monitor and manage treatment-related adv...

In this episode, CANCER BUZZ speaks with Bart Daugherty, vice president of clinical technology and systems at Georgetown Cancer Center, Lifepoint Health , about his program's receipt of a 2025 ACCC Innovator Award. Lifepoint's innovation, Transforming Cancer Detection and Treatment with the AI-Driven Healthy Person Program , leverages artificial intelligence (AI) to analyze the health records of a...

In this episode, CANCER BUZZ speaks with Andrew Munchel, MSN, RN, OCN, CPHQ, quality program administrator, oncology service line at WellSpan Health, WellSpan Cancer Institute about his program's receipt of a 2025 ACCC Innovator Award. WellSpan Cancer Institute's innovation, Adopting Machine Learning-Enabled Decision Support to Improve Oncology End-of-Life Outcomes , involved the implementation of...

In this episode, CANCER BUZZ speaks with Anna Liza Rodriguez, MSN, MHA, RN, OCN, NEA-BC, chief nursing officer and vice president of N ursing and P atient C are S ervices at Fox Chase Cancer Center about her program's receipt of a 2025 ACCC Innovator Award. Fox Chase Cancer Center's innovation, Ambulatory Care Excellence (ACE): Charting a New Path in Ambulatory Care Model and Coordination , is a s...